106 related articles for article (PubMed ID: 15142671)
1. Hypermethylation of the CpG island of connexin 32, a candiate tumor suppressor gene in renal cell carcinomas from hemodialysis patients.
Yano T; Ito F; Kobayashi K; Yonezawa Y; Suzuki K; Asano R; Hagiwara K; Nakazawa H; Toma H; Yamasaki H
Cancer Lett; 2004 May; 208(2):137-42. PubMed ID: 15142671
[TBL] [Abstract][Full Text] [Related]
2. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
Zhang Q; Jin J; Tao Q
Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
[TBL] [Abstract][Full Text] [Related]
4. Methylation-associated silencing of TU3A in human cancers.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Int J Oncol; 2008 Oct; 33(4):893-9. PubMed ID: 18813805
[TBL] [Abstract][Full Text] [Related]
5. [Two CpG-islands of SEMA3B gene: methylation in clear cell renal cell carcinoma].
Loginov VI; Khodyrev DS; Pronina IV; Maliukova AV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Zabarovskiĭ ER; Braga EA
Mol Biol (Mosk); 2009; 43(6):1088-92. PubMed ID: 20088387
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation profile of kidney cancer.
Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
[TBL] [Abstract][Full Text] [Related]
7. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
Fujimoto E; Sato H; Shirai S; Nagashima Y; Fukumoto K; Hagiwara H; Negishi E; Ueno K; Omori Y; Yamasaki H; Hagiwara K; Yano T
Oncogene; 2005 May; 24(22):3684-90. PubMed ID: 15782139
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the 5'CpG island of the FHIT gene in clear cell renal carcinomas.
Kvasha S; Gordiyuk V; Kondratov A; Ugryn D; Zgonnyk YM; Rynditch AV; Vozianov AF
Cancer Lett; 2008 Jul; 265(2):250-7. PubMed ID: 18378390
[TBL] [Abstract][Full Text] [Related]
9. Multigene methylation analysis of conventional renal cell carcinoma.
Onay H; Pehlivan S; Koyuncuoglu M; Kirkali Z; Ozkinay F
Urol Int; 2009; 83(1):107-12. PubMed ID: 19641369
[TBL] [Abstract][Full Text] [Related]
10. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
[TBL] [Abstract][Full Text] [Related]
11. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
[TBL] [Abstract][Full Text] [Related]
12. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
Hagiwara H; Sato H; Shirai S; Kobayashi S; Fukumoto K; Ishida T; Seki T; Ariga T; Yano T
Life Sci; 2006 Apr; 78(19):2249-54. PubMed ID: 16289236
[TBL] [Abstract][Full Text] [Related]
13. [Methylation of the promoter region of the RASSF1A gene, a candidate tumor suppressor, in primary epithelial tumors].
Loginov VI; Maliukova AV; Seregin IuA; Khodyrev DS; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Kiselev LL; Zabarovskiĭ ER; Braga EA
Mol Biol (Mosk); 2004; 38(4):654-67. PubMed ID: 15456137
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
Sato H; Hagiwara H; Senba H; Fukumoto K; Nagashima Y; Yamasaki H; Ueno K; Yano T
Mol Carcinog; 2008 Jun; 47(6):403-9. PubMed ID: 18058801
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of connexin 32 gene expression through DNA methylation in a human renal cell carcinoma cell.
Hirai A; Yano T; Nishikawa K; Suzuki K; Asano R; Satoh H; Hagiwara K; Yamasaki H
Am J Nephrol; 2003; 23(3):172-7. PubMed ID: 12690227
[TBL] [Abstract][Full Text] [Related]
16. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
[TBL] [Abstract][Full Text] [Related]
17. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.
Fujimoto E; Satoh H; Negishi E; Ueno K; Nagashima Y; Hagiwara K; Yamasaki H; Yano T
Mol Carcinog; 2004 Jul; 40(3):135-42. PubMed ID: 15224345
[TBL] [Abstract][Full Text] [Related]
18. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
[TBL] [Abstract][Full Text] [Related]
19. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma].
Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA
Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
